Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

  • This share is currently suspended. It was suspended at a price of 2,450.00
  • There is currently no data for FDP

Acquisition

15 Sep 2008 07:00

RNS Number : 3928D
First Derivatives PLC
15 September 2008
 

15 September 2008

First Derivatives plc 

(AIM:FDP.L, IEX:GYQ.I)

Acquisition of Market Resource Partners

The Board of First Derivatives plc ("First Derivatives" or the "Company") announces that it has acquired Market Resource Partners LLC ("MRP"), a US based technology marketing company headquartered in Philadelphia, PA, for a total consideration of up to $20 million (£11.3m) (the "Acquisition"). The Acquisition comprises an initial cash payment of $4.5m (£2.5m) and a further $1.5m (£0.8m) through the issue of 436,644 First Derivatives new ordinary shares (the "Consideration Shares"). An additional deferred consideration of up to a maximum of $14m (£7.9m) (will be payable, subject to MRP achieving certain profit goals during the two years ending 31 August 2010. The initial cash consideration will be financed from the Company's existing bank facilities.

Founded in 2002, MRP specializes in the strategic development and tactical execution of marketing and sales programs for software and technology service firms. Utilizing MRP's strategic consulting and predictive analytics, clients are in a position to make more informed decisions leading to immediate and longer term sales opportunities. MRP's clients comprise technology firms, Independent Software Vendors and channel resellers including Microsoft, Sun Microsystems and Cisco Systems. MRP employs 95 people in its office in Philadelphia, PA.

MRP achieved an EBITDA of $838,000 (£474,000) in the 12 months to 31 December 2006 and EBITDA of $335,000 (£190,000) in the 12 months to 31 December 2007 after adjusting for one-off costs of $163,000 (£92,000) from relocating their head office. In the six months to 30 June 2008 MRP achieved EBITDA of $653,000 (£369,000). The vendors have warranted that MRP's net assets as at 31 August 2008 (the effective date of the transaction) were not less than $200,000 (£113,000).

The Acquisition enhances First Derivatives presence in its largest market and will help accelerate the Company's expansion into the US by enhancing its global support offering. MRP will also provide another channel to market, for the Company's products, not only to the financial sector but also to other market segments.

The Consideration Shares will rank pari passu with the Company's existing ordinary shares. Application will be made for the Consideration Shares to be admitted to trading on AIM and the IEX and dealings are expected to commence on 19 September 2008. Following Admission the enlarged issued share capital of the Company will be 13,720,468 Ordinary Shares.

First Derivatives' CEO Brian Conlon said: "MRP is one of the leaders in its field and the continuing loyalty of its customer base, which is a roll call of the world's leading technology firms, is testimony to the quality of service it provides. This transaction represents a coming together of two very like minded firms with a mutual emphasis on professionalism and customer-driven innovation.

This Acquisition gives us access to an established team of world class technology marketing professionals. We have invested significant resources in R&D and this accelerates our channel to market particularly in the U.S. and into sectors other than investment banking. The investment will also provide a springboard for establishing a greater presence in the US market and will enable us to replicate our successful nearshore model in North America"

Kevin Cunningham of MRP said "We are excited about the opportunities that this transaction provides for MRP, our clients, and our employees. It allows us to accelerate the build out of our technology infrastructure and analytic capabilities, giving us the operational scale to meet our increasingly complex client needs. It also enables us to expand further our European operations and expertise in the financial technology sector, opening up new, more diverse business opportunities for MRP."

Contact:

First Derivatives plc

Brian Conlon

Michael O'Neill

Tel: +44 (0)28 3025 2242

Charles Stanley Securities

Nominated Adviser

Russell Cook/Carl Holmes

Tel: +44 (0)20 7149 6000

Goodbody Corporate Finance 

IEX Adviser

Finbarr Griffin/ Diane Hodgson

Tel: +353 1 667 0420

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQGUUPWBUPRGAC
Date   Source Headline
9th May 20257:00 amRNSForm 8.3 - FD Technologies plc
8th May 20253:26 pmRNSForm 8.3 - FD Technologies PLC
8th May 20253:22 pmPRNForm 8.3 - FD Technologies plc
8th May 20253:20 pmRNSForm 8.3 - FD Technologies plc
8th May 20253:20 pmRNSForm 8.3 - FD Technologies plc
8th May 20252:49 pmRNSForm 8.3 FD TECHNOLOGIES PLC
8th May 20251:51 pmRNSForm 8.3 - FD TECHNOLOGIES PLC
8th May 202511:24 amRNSForm 8.3 - FD Technologies PLC
8th May 202511:13 amRNSForm 8.5 (EPT/RI) - FD Technologies plc
8th May 202510:02 amRNSForm 8.5 (EPT/NON-RI) FD Technologies plc
8th May 20259:53 amGNWForm 8.5 (EPT/RI) - FD Technologies Plc
8th May 20257:00 amRNSRECOMMENDED ACQUISITION OF FD TECHNOLOGIES PLC
7th May 202511:26 amRNSStatement regarding Possible Offer
16th Apr 20257:44 amRNSHolding(s) in Company
11th Apr 20251:25 pmRNSIssue of Equity
2nd Apr 20258:49 amRNSIssue of Equity
25th Mar 20257:00 amRNSTrading Statement
7th Mar 20259:24 amRNSHolding(s) in Company
4th Feb 20253:57 pmRNSIssue of Equity
4th Feb 20252:45 pmRNSHolding(s) in Company
3rd Feb 20252:36 pmRNSHolding(s) in Company
3rd Feb 202510:19 amRNSHolding(s) in Company
31st Jan 20254:01 pmRNSHolding(s) in Company
30th Jan 20252:09 pmRNSHolding(s) in Company
24th Jan 20257:00 amRNSTENDER OFFER RESULTS AND TOTAL VOTING RIGHTS
20th Jan 20257:00 amRNSHolding(s) in Company
15th Jan 20252:20 pmRNSRESULTS OF GENERAL MEETING
8th Jan 20251:36 pmRNSHolding(s) in Company
8th Jan 20257:00 amRNSIssue of Equity
19th Dec 20245:00 pmRNSPublication of Circular Notice of GM
19th Dec 20247:00 amRNSProposed Tender Offer
13th Dec 20244:54 pmRNSIssue of Equity
13th Dec 20247:00 amRNSNotification of Long-Term Incentive Award to PDMR
3rd Dec 20247:00 amRNSCOMPLETION OF DIVESTMENT OF FIRST DERIVATIVE
26th Nov 20247:00 amRNSInterim Results
14th Nov 20247:00 amRNSProposed Divestment - Satisfaction of Conditions
11th Nov 20244:22 pmRNSNotice of Results
7th Nov 20248:54 amRNSHolding(s) in Company
24th Oct 202412:37 pmRNSResult of General Meeting
8th Oct 20245:00 pmRNSPublication of Circular and Notice of GM
8th Oct 20242:35 pmRNSHolding(s) in Company
7th Oct 20247:00 amRNSProposed Divestment
5th Sep 20242:39 pmRNSHolding(s) in Company
1st Aug 20248:43 amRNSTotal Voting Rights
18th Jul 20244:45 pmRNSResult of AGM
9th Jul 20241:56 pmRNSHolding(s) in Company
4th Jul 202410:36 amRNSHolding(s) in Company
2nd Jul 20244:30 pmRNSIssue of Equity
2nd Jul 20242:17 pmRNSHolding(s) in Company
1st Jul 20245:39 pmRNSPDMR Notice and Issue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.